Halotherapy Benefits: What Research Says About Salt Therapy

Halotherapy — the practice of breathing in fine, dry salt aerosol in a controlled environment — has roots stretching back to 19th-century Polish salt miners who experienced remarkably low rates of respiratory illness. Today, salt caves and salt rooms use halogenerators to recreate that microclimate, dispersing pharmaceutical-grade sodium chloride as a microscopic aerosol that you breathe during a 30-60 minute session.

But does it work? The research landscape has shifted meaningfully since 2023, with several new studies probing the specific biological pathways through which salt therapy acts. This article examines the current evidence, separating research-supported benefits from claims that still need more rigorous study.

How Halotherapy Works

The Active Ingredient

A halogenerator grinds pharmaceutical-grade sodium chloride (NaCl) into particles ranging from 1 to 10 microns in diameter. These dry salt microparticles are dispersed into the ambient air of a sealed room, typically maintained at 18-24°C with 40-60% relative humidity.

Mechanism of Action

When inhaled, these salt particles interact with the respiratory system in several ways:

Mucolytic effect: Salt draws water into the airways through osmosis, thinning and loosening mucus for easier clearance
Anti-inflammatory action: Recent pyroptosis research (2023, 2025) shows salt particles may reduce inflammation by downregulating the NLRP3 inflammasome pathway — a specific molecular cascade involved in inflammatory cell death
Antibacterial properties: High salt concentrations create a hostile environment for bacteria and viruses, potentially inhibiting pathogen growth in the airways
Electrophysiological effects: Salt ions may influence the electrical activity of airway cells, improving mucociliary clearance (the mechanism that moves mucus out of the lungs)
IgE reduction: Studies have documented reduced immunoglobulin E (IgE) levels, a key antibody involved in allergic responses
Skin contact: Salt particles landing on the skin may improve barrier function, reduce inflammation, and normalize pH

Active vs Passive Salt Rooms

Not all salt therapy environments are equal:

Active halotherapy rooms: Use a halogenerator to disperse precise concentrations of salt aerosol. This is true halotherapy with measurable salt particle delivery.
Passive salt rooms: Rooms decorated with salt walls, salt lamps, or salt floors but without a halogenerator. These environments do not produce meaningful salt aerosol concentrations and should not be considered therapeutic halotherapy.

The distinction matters — research on halotherapy applies only to active systems with controlled aerosol delivery. If you're not sure what type a facility uses, our guide on choosing a quality salt cave covers the key indicators.

Benefits With Moderate Research Support

Respiratory Function

This is the most studied application of halotherapy, and the evidence base has grown stronger in recent years.

The 2025 ARDS Study (Discover Medicine):

Prospective, randomized controlled study of 97 patients with moderate-to-severe acute respiratory distress syndrome
Halotherapy significantly reduced inflammatory biomarkers: NLRP3, IL-1β, Caspase-1, and MMP3
Lung function measures (FVC and FEV1) improved significantly in the treatment group
Major adverse cardiac events and renal dysfunction decreased
The study identified pyroptosis suppression as the key mechanism — halotherapy reduces inflammatory cell death in lung tissue

The 2023 COPD Pyroptosis Study (Annals of Translational Medicine):

Demonstrated halotherapy relieved COPD by inhibiting the NLRP3/ASC/Caspase-1 signaling pathway
Reduced lung inflammatory cell infiltration and airway wall attenuation
Relieved oxidative stress in lung tissue
Reduced CD4+ and CD8+ T cell accumulation and decreased inflammatory factor production
Also inhibited the TLR4/NF-κB/GSDMD pathway, a separate inflammatory signaling cascade

The 2021 Umbrella Review:

Examined 18 studies on dry salt therapy
Found consistent, modest improvements in peak expiratory flow rate (PEFR) and forced expiratory volume in one second (FEV1)
Only one included trial met rigorous randomized controlled trial criteria
Concluded that while findings are encouraging, methodological quality across studies is generally low

2024 Pediatric Asthma Study:

Found that halotherapy combined with respiratory gymnastics improved functional status in children with bronchial asthma
Contributed to improved quality of life
Published in the Journal of IMAB

Ongoing Clinical Trial (NCT06250452):

A registered randomized controlled trial studying the effect of halotherapy specifically in children with asthma
Double-blind design comparing salt room with halogenerator vs salt room without
Measures bronchial hyper-responsiveness, fractional exhaled nitric oxide, and quality of life
Results pending — this trial represents the kind of rigorous methodology the field needs

For a deeper look at how salt therapy affects specific respiratory conditions, see our detailed guide on halotherapy for respiratory health: asthma, allergies, and COPD.

The Pyroptosis Connection — Why It Matters

Two studies from 2023 and 2025 have converged on the same finding: halotherapy appears to work, at least in part, by suppressing pyroptosis. That word deserves a plain-language explanation.

Pyroptosis is a form of inflammatory cell death. When the body detects danger (infection, tissue damage), immune cells can essentially self-destruct in a way that releases inflammatory signals. In chronic respiratory disease, this process runs out of control — too much pyroptosis leads to chronic inflammation, tissue damage, and worsening symptoms.

The NLRP3 inflammasome is the molecular switch that triggers pyroptosis. Both the 2023 COPD study and the 2025 ARDS study found that halotherapy downregulates this switch, reducing the cascade of inflammatory cell death. This gives researchers a specific, testable mechanism — a major step beyond earlier studies that simply measured symptom improvement without explaining why.

Mucus Clearance

The osmotic properties of inhaled salt draw water into the airway lumen
Increased fluid thins viscous mucus, making it easier to clear through coughing and mucociliary transport
This mechanism is well-established for nebulized hypertonic saline (medical-grade salt inhalation) and plausibly extends to halotherapy aerosol
Patients with bronchiectasis and cystic fibrosis use prescription hypertonic saline nebulization based on similar principles
A three-month study of twice-weekly salt therapy sessions showed dramatic improvements in health and quality of life across participants ranging from healthy to those with COPD and asthma

For a comparison of halotherapy and medical nebulizer treatments, see our article on halotherapy vs nebulizer: comparing salt delivery methods.

Skin Conditions

Research on halotherapy for skin conditions shows promise through multiple mechanisms:

A study of 112 children with eczema found a positive response in 78% after 24 months of treatment, with improved dermatological status and immune homeostasis
Psoriasis patients showed significant improvement in severity scores after halotherapy sessions
Dead Sea salt bath studies found that a 5% Dead Sea salt bath solution used for 15 minutes daily over 6 weeks significantly improved skin hydration, roughness, and redness
Salt-balneo-phototherapy (saltwater baths paired with UVB light) has the strongest dermatological evidence base, showing improvements in plaque psoriasis beyond UVB alone
The proposed mechanism involves improved skin microcirculation, enhanced electrophysiological activity of skin cells, and pH normalization

Our salt therapy for skin conditions guide covers the dermatological research in more detail.

Benefits With Limited Research Support

Allergies

Some patients report reduced allergy symptoms after halotherapy courses
The documented reduction in IgE levels provides a plausible mechanism for allergy relief
The anti-inflammatory and mucolytic effects could theoretically benefit allergic rhinitis
Formal clinical trials specific to seasonal allergies are lacking
The American Academy of Allergy, Asthma & Immunology has not endorsed halotherapy for allergies

Read more in our dedicated article on halotherapy for seasonal allergies.

Sinus Conditions

Salt water nasal irrigation (neti pots, saline sprays) is well-established for sinus conditions
Halotherapy delivers salt to the sinuses through a different mechanism (aerosol inhalation)
Anecdotal reports of sinus symptom improvement are common
Controlled trials specific to sinusitis are limited

Stress and Relaxation

The salt cave environment itself — dim lighting, comfortable seating, quiet atmosphere — promotes relaxation
A study in the Journal of Alternative and Complementary Medicine found individuals undergoing halotherapy reported lower stress levels and improved mood
It is difficult to separate the effects of the salt aerosol from the effects of spending 45 minutes in a calming environment
The relaxation benefit is real but may not be specific to halotherapy itself

For more on the relaxation dimension, see our article on halotherapy and stress relief.

Immune Function

Salt's antibacterial and antiviral properties are well-documented in laboratory settings
The 2025 ARDS study showed halotherapy reduced inflammatory biomarkers in a clinical setting, suggesting real immune modulation
Whether brief inhalation of salt aerosol meaningfully enhances day-to-day immune function in healthy people is unproven
Some proponents cite reduced sick days among regular halotherapy users, but controlled studies on prevention are absent

What Major Medical Organizations Say

American Lung Association

The ALA has stated: "There is not enough evidence to recommend halotherapy as a medical treatment." They acknowledge that some patients report symptom relief but emphasize the need for larger, well-designed clinical trials. Their position has not changed despite the 2025 ARDS study — they are waiting for replication and larger sample sizes.

Cleveland Clinic

Cleveland Clinic describes halotherapy as an "alternative therapy that is not regulated in the same way as traditional practices" and notes that safety cannot be guaranteed across different practitioners.

Global Wellness Institute

The GWI maintains a research summary page noting that clinical trials have confirmed positive effects on patients with chronic respiratory diseases, improving mucociliary elimination and lung function. They emphasize the need for more randomized clinical trials.

The Evidence Gap — And How It's Closing

The evidence landscape is genuinely different in 2026 than it was even two years ago. Here's an honest assessment:

What's improved:

The 2025 ARDS study is a proper randomized controlled trial with 97 patients — not a small pilot
Two studies (2023, 2025) have identified a specific molecular mechanism (NLRP3 pyroptosis suppression), moving beyond symptom-only measurement
An ongoing registered clinical trial (NCT06250452) for pediatric asthma uses double-blind methodology
The 2024 pediatric study adds to the growing body of asthma evidence

What still needs work:

Study quality: Most published studies remain observational, uncontrolled, or use small sample sizes
Standardization: There is no universally accepted halotherapy protocol (salt concentration, particle size, session duration, number of sessions)
Placebo control difficulty: It is challenging to create a convincing sham treatment for halotherapy
Regulatory status: Halotherapy is not FDA-regulated as a medical treatment, which limits research funding
Industry-funded research: Some studies are funded by halotherapy equipment manufacturers, raising potential bias concerns
Replication: The pyroptosis findings need independent replication across multiple research groups

For a broader look at where halotherapy research is headed, see our latest clinical studies overview.

Practical Considerations

Who May Benefit Most

Based on available evidence and clinical reasoning:

People with chronic respiratory conditions who have not found complete relief from conventional treatments
Individuals with excessive mucus production
Those with mild-to-moderate asthma or allergies seeking complementary approaches
People with skin conditions like eczema or psoriasis (as a complement to dermatological care)
Individuals seeking a relaxing, drug-free wellness experience
Athletes looking for respiratory support (see our guide on halotherapy for athletes)

Who Should Exercise Caution

Active respiratory infections with fever: Wait until the acute infection resolves
Severe asthma: Inhaled salt can trigger bronchoconstriction in some asthmatics — discuss with your pulmonologist first
Hemoptysis (coughing blood): Do not use halotherapy until the cause is identified and treated
Active tuberculosis or other contagious respiratory diseases: Risk of spreading infection
Hypersensitivity to salt: Rare but possible

For a full rundown of safety considerations, read our article on halotherapy side effects.

What to Expect Cost-Wise

Salt cave sessions typically range from $25-$65 per session depending on your city. Many facilities offer package deals that bring the per-session cost down. Our 2026 pricing guide breaks down costs by region.

Frequently Asked Questions

Is halotherapy FDA-approved?

No. Halotherapy is classified as a wellness practice, not a medical treatment. The FDA has not approved halotherapy devices for the treatment of any specific medical condition. This means there are no federally mandated standards for salt concentration, particle size, or session protocols. However, new clinical research — particularly the 2025 ARDS randomized controlled trial — is building the kind of evidence base that could eventually support regulatory consideration.

How does halotherapy compare to a nebulizer with saline?

Nebulized hypertonic saline is a prescription treatment with a stronger evidence base, particularly for cystic fibrosis and bronchiectasis. It delivers a higher concentration of salt directly to the airways through a mouthpiece. Halotherapy delivers a lower concentration of dry salt aerosol through ambient room air. The two are related in mechanism but different in delivery and evidence level. Both may work partly through the same NLRP3 inflammasome pathway identified in the 2023 and 2025 studies.

Can halotherapy replace my asthma inhaler?

No. Halotherapy should never replace prescribed asthma medication. It may serve as a complementary practice alongside your prescribed treatment plan. The 2024 pediatric study found benefits when halotherapy was combined with standard respiratory exercises — not used as a substitute. Always consult your pulmonologist before adding any complementary therapy to your asthma management.

How many sessions does it take to notice benefits?

Respiratory benefits are most commonly reported after 7-12 sessions. A three-month study using twice-weekly sessions showed significant improvements in health and quality of life. Some people notice mild improvement after a single session (clearer breathing, reduced congestion), while others require a full course. Most salt caves recommend an initial series of 10-15 sessions for respiratory conditions.

Is breathing salt really safe for your lungs?

In the concentrations used in halotherapy (typically 1-10 mg per cubic meter of air), inhaled dry salt particles are generally considered safe for most people. The amount of salt inhaled during a session is a tiny fraction of normal dietary intake. The 2025 ARDS study reported no significant adverse events in the treatment group. However, for people with reactive airways (severe asthma, hyperresponsive bronchial disease), even small amounts of inhaled particles can trigger coughing or bronchoconstriction.

The Bottom Line

Halotherapy has moved from "plausible mechanism, thin evidence" to "plausible mechanism, growing evidence" — particularly for respiratory conditions. The identification of the NLRP3 pyroptosis pathway as a specific mechanism in both COPD (2023) and ARDS (2025) gives researchers a concrete target to study, and the 2025 randomized controlled trial of 97 patients represents a meaningful step up in study quality.

It is still not a proven medical treatment by mainstream standards. The ALA and Cleveland Clinic positions haven't changed. But the trajectory of the research is toward stronger evidence, not weaker. The ongoing pediatric asthma RCT (NCT06250452) could be another important data point.

For people seeking a complementary wellness practice with a good safety profile, halotherapy is a reasonable option — particularly when combined with evidence-based medical treatments rather than used as a replacement.

Quick Answer